Ptie stock price target

PTIE Pain Therapeutics, Inc. stock Pain Therapeutics, Inc. (NASDAQ: PTIE) closed at per share at the end of the most recent trading day (a % change compared to the prior day closing price) with a volume of 0.0000 shares and market capitalization of 21.35M.Is a component of indexes and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs people.

What every investor should know about analysts' price ... Mar 29, 2012 · If the stock hits the target within the 12-month period, however, it doesn't necessarily mean the investor should sell. That's because the analyst may well have changed his or … PTIE -- Is Its Stock Price A Worthy Investment? Learn More. Pain Therapeutics, Inc. (PTIE) Company Bio Pain Therapeutics, Inc., a biopharmaceutical company, develops novel drugs in the United States. The company s lead drug candidate is REMOXY, a proprietary abuse-deterrent oral formulation of oxycodone for pain relief. Price Target | Benzinga Jan 01, 2010 · Dollar General (NYSE: DG) shares are trading higher on Wednesday after Citigroup maintained a Buy rating on the stock and raised its price target …

Market Data by Xignite and BATS BZX Real-Time Price. Securities products and services offered to self-directed investors through ST Invest, LLC. Member FINRA / SIPC. ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk,

Pain Therapeutics, Inc. (NASDAQ:PTIE) Pain Therapeutics, Inc. (NASDAQ:PTIE) closed at $1.24 on the last trading session with an increase of 0%, whereas, it previously closed at $1.24. The company has a market capitalization of $0. The company traded shares of 0 on the trading day while its three month average volume stands at 284.77 Million. Now to discuss some of the Earning per Share Lookout for these Two stocks: Pain Therapeutics, Inc ... The Stock currently has Analyst’ mean Recommendation of 0 where the scale is from 1 to 5, 1 means Strong Buy and 5 means Sell. The 1 analysts offering 12-month price forecasts for Pain Therapeutics Inc have a median target of 23.75, with a high estimate of 23.75 and a low estimate of 23.75. Pre-Open Movers 06/27: (DFBG) (CARA) (I) Higher; (AQXP ... Mammoth Energy Services, Inc. (Nasdaq: TUSK) 1% LOWER; launch of an underwritten public offering of 4,000,000 shares of its common stock by certain selling stockholders, subject to market and NUGL Stock Forecast: down to 0.000001 USD? - NUGL Stock ... NUGL Stock Price Forecast, NUGL stock price prediction. Price target in 14 days: 0.123 USD. The best long-term & short-term NUGL share price prognosis for 2020, 2021

Stock: PTIE, Company: Pain Therapeutics, Description: Pain Therapeutics Inc is a biopharmaceutical company. It develops proprietary drugs that offer improvements to patients and healthcare professionals. The company generally focuses on the drug development efforts on disorders of the nervous system, such as chronic pain. Pain Therapeutics operates in the single operating segment.

Stock Analysis: What Is a Price Target? | Finance - Zacks The price target of a stock is the price at which the stock is fairly valued with respect to its historical and projected earnings. Investors can maximize their rates of return by buying and What every investor should know about analysts' price ... Mar 29, 2012 · If the stock hits the target within the 12-month period, however, it doesn't necessarily mean the investor should sell. That's because the analyst may well have changed his or … PTIE -- Is Its Stock Price A Worthy Investment? Learn More.

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET.

Apr 07, 2017 · Pain Therapeutics, Inc. (NASDAQ:PTIE) Austin, TX-based Pain Therapeutics, Inc. (NASDAQ:PTIE) is up over 58% in the pre-market on large volumes. This morning the biotech firm announced it has secured positive guidance from the Food and Drug Administration (FDA) for it lead drug candidate Remoxy ER – an opioid.

EPS Growth overview of Pain Therapeutics Inc. (NASDAQ:PTIE)

SATS Target Price (SGX:S58) | SG investors.io Oct 26, 2019 · View the most recent target price / fair value estimation changes @ Analysts Say > Latest Price Targets & Stock Ratings Walgreens Boots Alliance Reaches Analyst Target Price | Nasdaq Oct 30, 2018 · I n recent trading, shares of Walgreens Boots Alliance Inc (Symbol: WBA) have crossed above the average analyst 12-month target price of $76.44, changing hands for …

The Stock currently has Analyst’ mean Recommendation of 0 where the scale is from 1 to 5, 1 means Strong Buy and 5 means Sell. The 1 analysts offering 12-month price forecasts for Pain Therapeutics Inc have a median target of 23.75, with a high estimate of 23.75 and a low estimate of 23.75. Pre-Open Movers 06/27: (DFBG) (CARA) (I) Higher; (AQXP ...